Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles

Diabetes

Volumn 54, Issue 10, 2005, Pages 3002-3006

  Bouwman, Lee H ^a   Eerligh, Peter ^a   Terpstra, Onno T ^a   Daha, Mohamed R ^a   De Knijff, Peter ^a   Ballieux, Bart E P B ^a   Bruining, G Jan ^b   Van Der Slik, Arno R ^a   Roos, Anja ^a   Roep, Bart O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FRUCTOSAMINE; MANNOSE BINDING LECTIN;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CLINICAL FEATURE; COMPLEMENT SYSTEM; CONTROLLED STUDY; EXON; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD;

ADOLESCENT; AUTOANTIBODIES; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FRUCTOSAMINE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; MALE; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 25844472714     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.10.3002     Document Type: Article

References (27)

1. Virtanen SM, Knip M: Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 78:1053-1067, 2003
2. Yoon JW, Jun HS: Viruses in type 1 diabetes: brief review. ILAR J 45:343-348, 2004
3. Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD: A role for innate immunity in type 1 diabetes? Diabete Metab Res Rev 19:89-100, 2003
4. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ: KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52:2639-2642, 2003
5. Wen L, Peng J, Li Z, Wong FS: The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J Immunol 172:3173-3180, 2004
6. Carroll M: Innate immunity in the etiopathology of autoimmunity. Nat Immunol 2:1089-1090, 2001
7. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U, Reid KB, Jensenius JC: A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510, 1997
8. Turner MW, Hamvas RM: Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2:305-322, 2000
9. Eisen DP, Minchinton RM: Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37:1496-1505, 2003
10. Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, Bouwman LH, Schlagwein N, Fallaux van den Houten FC, Faber-Krol MC, Madsen HO, Schwaeble WJ, Matsushita M, Fujita T, Daha MR: Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 34:2589-2598, 2004
11. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A: Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155:3013-3020, 1995
12. Garred P, Larsen F, Madsen HO, Koch C: Mannose-binding lectin deficiency: revisited. Mol Immunol 40:73-84, 2003
13. Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S: Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J Mol Med 83:308-315, 2005
14. Garred P, Voss A, Madsen HO, Junker P: Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2:442-450, 2001
15. Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D: Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet 1:668-672, 1980
16. Saraheimo M, Forsblom C, Hansen TK, Teppo AM, Fagerudd J, Pettersson-Fernholm K, Thiel S, Tarnow L, Ebeling P, Flyvbjerg A, Groop PH: Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48:198-202, 2005
17. Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A: Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53:1570-1576, 2004
18. Hovind P, Hansen TK, Tarnow L, Thiel S, Steffensen R, Flyvbjerg A, Parving HH: Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 54:1523-1527, 2005
19. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
20. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC: An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 257:107-116, 2001
21. Batstra MR, Petersen JS, Bruining GJ, Grobbee DE, de Man SA, Molenaar JL, Dyrberg T, Aanstoot HJ: Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. Hum Immunol 62:1106-1110, 2001
22. Schipper RF, Koeleman BP, Bruining GJ, Schreuder GM, Verduijn W, De Vries RR, Roep BO: HLA class II associations with type 1 diabetes mellitus: a multivariate approach. Tissue Antigens 57:144-150, 2001
23. Suankratay C, Mold C, Zhang Y, Potempa LA, Lint TF, Gewurz H: Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP). Clin Exp Immunol 113:353-359, 1998
24. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den BG: Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088, 2003
25. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T: Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 165:2637-2642, 2000
26. Petersen SV, Thiel S, Jensen L, Vorup-Jensen T, Koch C, Jensenius JC: Control of the classical and the MBL pathway of complement activation. Mol Immunol 37:803-811, 2000
27. Hansen TK, Thiel S, Knudsen ST, Gravholt CH, Christiansen JS, Mogensen CE, Poulsen PL: Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 88:4857-4861, 2003